Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment
- First Posted Date
- 2011-11-09
- Last Posted Date
- 2015-08-17
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 47
- Registration Number
- NCT01468077
A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 99
- Registration Number
- NCT01462175
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2016-10-31
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 122
- Registration Number
- NCT01462162
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
- Conditions
- Non-Hodgkin's Lymphoma
- Interventions
- Drug: Chemotherapy (Induction Period)
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2019-08-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 692
- Registration Number
- NCT01461928
- Locations
- 🇧🇬
Tokuda Hospital Sofia; Hematology department, Sofia, Bulgaria
🇦🇹Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Hämatologie & Hämostaseologie, Wien, Austria
🇨🇴Instituto Nacional de Cancerologia; Hematology, Bogota, Colombia
A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 49
- Registration Number
- NCT01461967
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 30
- Registration Number
- NCT01461057
- Locations
- 🇨🇿
Fakultni nemocnice Olomouc; Onkologicka klinika, Olomouc, Czechia
🇧🇪UZ Leuven Gasthuisberg, Leuven, Belgium
🇮🇹Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milano, Lombardia, Italy
An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2016-01-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 228
- Registration Number
- NCT01461044
ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?
- Conditions
- Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
- Interventions
- Device: Aviva Expert blood glucose meterDevice: Aviva Nano blood glucose meter
- First Posted Date
- 2011-10-26
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 218
- Registration Number
- NCT01460446
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 357
- Registration Number
- NCT01457677
A Study of RO4995819 in Healthy Elderly Volunteers
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 30
- Registration Number
- NCT01457664